STOCKWATCH
·
Pharmaceuticals
Business Update18 Jul 2025, 04:13 pm

Lasa Supergenerics Ltd: Factory Operations Halted Post Fire Incident

AI Summary

Lasa Supergenerics Ltd has announced that their manufacturing facility, which was affected by a fire incident on 18th May 2025, cannot be resumed due to pending statutory clearances and operational constraints. The company is now considering contract manufacturing arrangements and/or leasing the facility, subject to regulatory approvals and consents. They assure stakeholders of maintaining transparency and providing timely updates on material developments.

Key Highlights

  • Factory operations cannot be resumed due to pending statutory clearances and operational constraints
  • Company considering contract manufacturing arrangements and/or leasing the facility
  • Regulatory approvals and consents are required
  • Lasa Supergenerics committed to maintaining transparency
  • Timely updates will be provided on material developments
LASA
Pharmaceuticals
Lasa Supergenerics Ltd

Price Impact